Vimarsana
Biggest News Aggregation in the World

Page 21 - Published October News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Published October. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Published October Today - Breaking & Trending Today

TRIO-SSS hosts peer mentorship event - Vimarsana News

TRIO-SSS hosts peer mentorship event

The ULM Student Support Services TRIO Program (TRIO-SSS) recently organized an exciting and impactful event that brought together incoming freshmen TRIO participants and their peer mentors. Held at Bayou Bowl on September 14, 2023, this event served not only as a fun-filled bonding experience but also as an opportunity to highlight the significance of peer mentorship in the lives of first-generation college students.

Source: ulm.edu
Stingers 74, Timberwolves 67: Stingers win their first game of the Concordia Classic. | Sports - Vimarsana News

Stingers 74, Timberwolves 67: Stingers win their first game of the Concordia Classic. | Sports

Stingers survive late game comeback by UNBC Timberwolves in the home opener of Concordia Classic tournament

18th annual MMIWG2S+ vigil calls for justice and healing | News - Vimarsana News

18th annual MMIWG2S+ vigil calls for justice and healing | News

Several speakers called out governmental inaction during the event and pointed out the various issues with Quebec’s institutions.

Stingers 53, Varsity Blues 49: Concordia takes the lead in the Concordia Classic | Sports - Vimarsana News

Stingers 53, Varsity Blues 49: Concordia takes the lead in the Concordia Classic | Sports

The Stingers prevailed despite strong efforts from the Varsity Blues.

Paxlovid Tied to Benefits in High-Risk Patients With COVID - Vimarsana News

Paxlovid Tied to Benefits in High-Risk Patients With COVID

The use of nirmatrelvir–ritonavir (Paxlovid) is associated with a lower risk for death or hospitalization in extremely vulnerable patients with COVID-19. Low-risk patients do not appear to benefit.